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Abstract 
Carcinoma of the papilla of Vater is a relatively rare tumor and its coexistence with 
other primary sporadic cancers is very exceptional. Here we report the case of a 
76-year-old man who presented with painless obstructive jaundice, pathologically 
elevated liver function tests and increased serum levels of carbohydrate antigen 19-9 
and carcinoembryonic antigen. Endoscopic retrograde cholangiography revealed a 
large polypoid mass in the ampulla of Vater. A large tumor in the ascending colon 
was also incidentally detected by abdominal computed tomography. Endoscopic 
biopsies from both lesions showed adenocarcinomas. Metastases to the liver and to 
the hepatoduodenal ligament and hepatic artery lymph nodes were found during 
surgery. Right colectomy and a biliary bypass were performed. Histological analysis 
showed an ampullary adenocarcinoma with metastases to regional lymph nodes and 
the liver and a colonic adenocarcinoma with local invasion into the pericolic fat. 
Treatment with gemcitabine plus cisplatin was suggested postoperatively. The 
association of sporadic ampullary and colonic adenocarcinomas and the mutually 
increased risk of developing either a synchronous or a metachronous tumor following 
each other should be considered in patients with primary ampullary or colorectal cancer 
during the preoperative evaluation and postoperative follow-up of these patients. Case Rep Gastroenterol 2011;5:301–307 
DOI: 10.1159/000329344 
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Introduction 
Carcinoma of the papilla of Vater is a relatively uncommon tumor accounting for 
about 1% of all adenocarcinomas and approximately for 5% of gastrointestinal tract 
carcinomas. These tumors are diagnosed early because they produce clinical signs or 
symptoms of biliary obstruction at an early stage due to their location within the biliary 
tract, and have a good prognosis after surgical resection compared to other periampullary 
carcinomas, namely bile duct and pancreatic cancers. Ampullary carcinomas can be either 
sporadic or may be part of several inherited cancer syndromes where they may associate 
with colorectal cancer. Hereditary nonpolyposis colorectal cancer syndrome and familial 
adenomatous polyposis are two autosomal dominant syndromes of high penetrance, 
where extracolonic tumors such as endometrial, ovarian, gastric, intestinal, pancreatic 
and biliary tract cancers associate with colorectal cancer [1–4]. Peutz-Jeghers syndrome 
is also an autosomal dominant disorder characterized by the development of 
hamartomatous polyps in the entire gastrointestinal tract and mucocutaneous lesions of 
the lips and buccal mucosa, and associated with increased risk of both extraintestinal and 
gastrointestinal cancers most commonly in the colon and the duodenum. However, there 
is evidence that sporadic ampullary carcinomas may also associate either synchronously 
or metachronously with other malignancies such as sporadic colorectal carcinomas [5, 6]. 
In a population-based study, patients with ampullary cancer were found to be at increased 
risk for a second primary colorectal cancer and patients with colorectal cancer were found 
to be at increased risk for a second primary ampullary carcinoma [7]. This bidirectional, 
greater than chance, mutual association between these two cancers suggests common 
genetic, environmental or predisposing risk factors or shared mechanisms of 
carcinogenesis [7]. Here we describe a rare case of synchronous association of sporadic 
carcinoma of the papilla of Vater with sporadic colon cancer. 
Case Report 
A 76-year-old man was admitted because of painless obstructive jaundice of one week duration 
when he noticed yellow-colored scleras, dark-colored urine and stool discoloration. He also reported 
general fatigue, loss of appetite and weight loss (10 kg) over the last three months. There were no 
changes in his bowel movements and his past medical history and family history were negative for 
malignancy or familial cancer syndrome. On physical examination the skin and sclera appeared yellow. 
Abdominal examination revealed mild tenderness in the right upper abdominal quadrant, but no mass 
was palpable. There were no enlarged neck, axillary or inguinal lymph nodes. 
Laboratory tests revealed microcytic, hypochromic anemia, hematocrit 32.6% (reference range  
40–54%), hemoglobin 11.1 g/dl (reference range 13.5–17.5 g/dl), mean corpuscular volume 74.2 fl 
(reference range 76–96 fl), mean corpuscular hemoglobin 25.4 pg (reference range 27–34 pg), mean 
corpuscular hemoglobin concentration 31.3 g/dl (reference range 25–32 g/dl) and serum ferum and 
ferritin levels of 23 μg/dl (reference range 70–180 μg/dl) and 80 μg/l (reference range 30–400 μg/l), 
respectively. Liver function tests were all abnormally elevated: total bilirubin 13.6 mg/dl, direct 
bilirubin 10.7 mg/dl, alkaline phosphatase 1,066 U/l, aspartate aminotransferase 201 U/l, alanine 
aminotransferase 329 U/l, and γ-glutamyl transpeptidase 470 U/l. Serum levels of carbohydrate antigen 
19-9 and carcinoembryonic antigen were elevated at 540 U/ml (reference range 0–37 U/ml) and 
9.2 ng/ml (reference range 0.9–5.4 ng/ml), respectively. All other laboratory parameters were within 
normal limits and hepatitis B and C serology tests were negative. 
Abdominal ultrasonography showed a distended gallbladder, dilatation of the intra- and 
extrahepatic bile ducts but not gallstones. The performed computed tomography of the abdomen 
showed enlargement of the pancreatic head suggesting the presence of a tumor either in the pancreatic 
head or in the periampullary region (fig. 1). An irregular, 6-cm mass in the ascending colon with partial Case Rep Gastroenterol 2011;5:301–307 
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luminal obstruction was also incidentally found (fig. 2). There were neither metastatic lesions in the 
liver nor enlarged intraabdominal lymph nodes or ascites. An endoscopic retrograde cholangiography 
revealed a large polypoid mass in the ampulla of Vater (fig. 3). Endoscopic biopsies were taken and 
showed a poorly differentiated adenocarcinoma. Total colonoscopy showed no polyps but a large, 
ulcerated polypoid mass was found in the ascending colon. Biopsies were taken and the histology 
showed an adenocarcinoma. 
At operation, a large tumor in the ascending colon was found. In addition, five small-sized  
(2–3 mm) metastatic lesions were seen in the hepatic surface. Enlarged lymph nodes were present at 
the hepatic hilus, along the hepatoduodenal ligament and common hepatic artery. Intraoperative 
frozen sections from the hepatic lesions and the enlarged lymph nodes were both positive for 
adenocarcinoma. A decision was made to perform right colectomy because of anemia due to chronic 
blood loss and the possibility of bowel obstruction because of the large size of the tumor. A side to 
side hepaticojejunostomy was also performed for jaundice relief. Final histological analysis showed a 
moderately differentiated, mucinous adenocarcinoma of the colon with local invasion into the pericolic 
fat but without regional lymph node metastases (T3N0M0). The histological features of the examined 
lymph nodes and hepatic specimens were consistent with those of the ampulla of Vater lesion. Based on 
these findings, the diagnosis of adenocarcinoma of the ampulla of Vater with metastases to regional 
lymph nodes and the liver was made and the tumor was classified as stage IV (T3N1M1) according to 
the sixth edition (2002) of the TNM system. The patient’s postoperative course was uneventful and he 
was discharged on the eighth postoperative day. Treatment with gemcitabine plus cisplatin was 
proposed, but the patient refused any further treatment and eventually died two months later. 
Discussion 
Patients with malignant neoplasms are more likely to develop a second malignancy 
compared to the general population because of genetic susceptibility, due to common 
etiologic factors or as a result of treatment for the first cancer. Tumors of the papilla of 
Vater may be part of several inherited syndromes of polyposis or nonpolyposis colon 
cancer [1–4]. However, there is evidence that ampullary carcinoma is associated with a 
high incidence of other malignancies such as colorectal carcinomas [5–7] although case 
series failed to detect an association between ampullary and colorectal cancer [8, 9].  
Data from the Surveillance, Epidemiology, and End Results (SEER) Program showed a 
significantly elevated risk of colorectal cancer in women (relative risk (RR): 2.25, 95% 
confidence interval (CI): 1.16–3.94) but not in men (RR: 1.28, 95% CI: 0.58–2.42) 
diagnosed with bile duct cancer [6]. Several large population-based studies evaluated the 
association between noncolorectal and colorectal cancer in the reverse direction, namely 
the risk of a subsequent primary cancer following colorectal cancer. Data analysis from 
the SEER Program for the period 1975 through 2001 showed a significantly increased risk 
for both synchronous and metachronous occurrence for intestinal, gastric, kidney, 
prostate, female breast, and corpus uteri cancers [10]. Regarding hepatobiliary cancers, 
there was no overall increased risk for metachronous pancreatic or gallbladder cancer. 
However, significantly elevated risk for pancreatic cancer was found in younger (less 
than 50 years) patients. Interestingly, there were no cases of either synchronous or 
metachronous ampullary carcinomas in this study [10] or in colorectal cancer patients 
from the Thames Cancer Registry database [11] or from the Swedish Family-Cancer 
database [12]. However, these studies were not designed to evaluate the association 
between ampullary and colorectal cancers. Differences among cancer registries regarding 
cohort characteristics, disease reporting, synchronous or metachronous definition, length 
of follow-up and coding policy may also account for these discrepancies. Nevertheless, an 
excess risk of secondary ampullary cancer (standardized incidence ratio (SIR): 3.43; 95% Case Rep Gastroenterol 2011;5:301–307 
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CI: 1.37–7.06) following colon cancer was reported among five-year survivors [8]. 
Analysis of colorectal cancers from the SEER Program for the 1973–1993 period revealed 
a significantly increased risk of bile duct cancer in both men (RR: 1.96, 95% CI: 1.42–2.63) 
and women (RR: 1.59, 95% CI: 1.06–2.30) following colorectal cancer [6]. When data 
from the 1973–1999 period of the SEER Program were analyzed to specifically examine 
the association between ampullary and colorectal cancer, it was found that among 2,043 
white patients with ampullary cancer, a total of 30 developed colorectal cancer over 5,674 
person-years of follow-up, as compared with an expected number of 14 patients, thus 
yielding an overall SIR of 2.14 with a 95% CI of 1.45–3.06 [7]. The tumors were equally 
distributed along the colon and rectum in a pattern similar to that observed in the overall 
colorectal cancer SEER population. Eleven patients had localized disease, 9 patients had 
regional and 5 patients had metastatic disease. The median time from ampullary cancer 
diagnosis until diagnosis of the colorectal cancer was 5.25 years (25th–75th percentile: 
2.42–10.25 years) with 9 cases diagnosed within one year after diagnosis of the initial 
ampullary carcinoma. In contrast, 57 out of 262,066 white patients with colorectal cancer 
developed ampullary cancer as a second primary malignancy with an expected number of 
26 ampullary malignancies in this cohort (SIR: 2.18, 95% CI: 1.69–2.85). The median time 
between colorectal and subsequent ampullary cancer diagnosis was 7.58 years (25th–75th 
percentile: 2.33–13.3 years) with 10 ampullary cancers detected within one year after 
diagnosis of the initial primary colorectal cancer. 
In our patient, a mucinous carcinoma of the colon and a poorly differentiated 
metastatic adenocarcinoma of the ampulla of Vater were diagnosed simultaneously. We 
considered these two cancers to be synchronous because they were histologically distinct 
without evidence of one being a metastasis of the other. They also appeared to be sporadic 
because a familial cancer syndrome was excluded by history and gastrointestinal polyposis 
was not found by endoscopy. SEER population-based studies showed a bidirectional 
association between ampullary and colorectal cancer for both genders with ampullary 
cancer patients having a risk for the development of colorectal cancer as a second primary 
malignancy of 2 and vice versa (SIR: 2.14 and 2.18, respectively). Interestingly, the second 
tumor was diagnosed within one year after diagnosis of the initial primary in 30% (9 out 
of 30 patients) of ampullary cancer patients and in 17.5% (10 out of 57 patients) of 
colorectal cancer patients, suggesting coincidently present tumors [7]. Synchronously 
diagnosed cancers may be the result of ‘lead time bias’ since the second tumor may be 
detected while asymptomatic because of increased medical scrutiny. In addition, when 
two cancers are diagnosed at the same time, which is designated as the index tumor might 
be arbitrarily defined as in our patient who presented with symptoms from the ampullary 
cancer whereas the colon cancer was diagnosed incidentally during the diagnostic 
work-up. Nevertheless, the association of a frequent cancer like colon cancer with 
ampullary cancer which is less frequent, the localized feature of the colon cancer as 
opposed to the metastatic ampullary cancer, along with morphological data from 
histological analysis and the course of the disease in this patient imply ampullary 
carcinoma as being the primary tumor. The bidirectional association between ampullary 
and colorectal cancer with almost equal SIRs suggests similar or common risk factors and 
mechanisms of carcinogenesis in these two tumors. Sporadic ampullary carcinomas are 
considered to arise from a preexisting adenoma similarly to the adenoma-carcinoma 
sequence in colorectal cancer [13–15]. They show histological features of a tubular 
colorectal adenocarcinoma and are characterized by a K-ras mutational rate and 
molecular alterations similar to that observed in colon cancer [16, 17]. This similarity Case Rep Gastroenterol 2011;5:301–307 
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of biological characteristics with colonic carcinomas may explain at least in part the 
growth pattern of ampullary carcinomas and the more favorable outcome as opposed 
to pancreatic and biliary tract carcinomas. When two primary cancers are diagnosed 
simultaneously, the systemic treatment should target the tumor with worst prognosis. In 
our patient systemic chemotherapy for metastatic ampullary cancer consisting of cisplatin 
plus gemcitabine combination was suggested because of the more advanced disease 
compared to the colon cancer. 
In summary, we report a synchronous detection of both presumably sporadic 
ampullary and colonic adenocarcinomas. The association of carcinoma of the papilla of 
Vater with colorectal cancer and the mutually increased risks of developing either a 
synchronous or metachronous tumor following each other should be considered in 
patients with primary ampullary or colorectal cancer during the preoperative evaluation 
and postoperative follow-up of these patients. 
 
 
 
 
 
 
Fig. 1. Abdominal computed tomography scan showing enlargement of the pancreatic head (arrows) 
indicative of a tumor either in the pancreatic head or in the periampullary region. D = Duodenum. 
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Fig. 2. Abdominal computed tomography scan demonstrating an irregular, large mass in the ascending 
colon (arrows) with partial luminal obstruction. 
 
 
 
Fig. 3. Endoscopic appearance of the polypoid mass in the ampulla of Vater (arrows) which was 
proven to be a poorly differentiated ampullary adenocarcinoma. 
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